SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Flagstaff, Arizona.
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorMedical
Phone928-779-4143
Debt
Current Ratio9.02
Quick Ratio7.88
Price-To-Earnings
Sales & Book Value
Annual Sales$50,000.00
Price / Sales382.99
Price / Cash FlowN/A
Price / Book1.70
Profitability
Net Income$-12,280,000.00
Net Margins-6,510.67%
Return on Assets-137.92%
Miscellaneous
Employees39
OptionableNot Optionable
SenesTech (NASDAQ:SNES) Frequently Asked Questions
What is SenesTech's stock symbol?
SenesTech trades on the NASDAQ under the ticker symbol "SNES."
How were SenesTech's earnings last quarter?
SenesTech Inc (NASDAQ:SNES) announced its earnings results on Monday, November, 12th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.03. The company had revenue of $0.11 million for the quarter. SenesTech had a negative return on equity of 169.43% and a negative net margin of 6,510.67%. View SenesTech's Earnings History.
When is SenesTech's next earnings date?
What guidance has SenesTech issued on next quarter's earnings?
SenesTech updated its third quarter 2018 earnings guidance on Thursday, October, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100K - 110K.
What is the consensus analysts' recommendation for SenesTech?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SenesTech.
Has SenesTech been receiving favorable news coverage?
News coverage about SNES stock has trended somewhat negative this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. SenesTech earned a news sentiment score of -1.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the immediate future.
Who are some of SenesTech's key competitors?
Some companies that are related to SenesTech include Evogene (EVGN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), Arcadia Biosciences (RKDA), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), Eden Research (EDEN), Monsanto (MON), Nufarm (NUF), Syngenta (SYT), Terra Nitrogen (TNH) and Wynnstay Group (WYN).
Who are SenesTech's key executives?
SenesTech's management team includes the folowing people:
- Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 69)
- Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 66)
- Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 59)
- Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 63)
- Mr. Joe Malinowski, VP of Sales
When did SenesTech IPO?
(SNES) raised $15 million in an initial public offering (IPO) on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.
How do I buy shares of SenesTech?
Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SenesTech's stock price today?
One share of SNES stock can currently be purchased for approximately $0.8166.
How big of a company is SenesTech?
SenesTech has a market capitalization of $19 million and generates $50,000.00 in revenue each year. The company earns $-12,280,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. SenesTech employs 39 workers across the globe.
What is SenesTech's official website?
How can I contact SenesTech?
SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]
MarketBeat Community Rating for SenesTech (NASDAQ SNES)
MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days.
